Researchers find RNA-guided enzymes are more diverse and widespread than previously believed.
Made of components found in the human body, the programmable system is a step toward safer, targeted delivery of gene editing and other molecular therapeutics.
The tabletop diagnostic yields results in an hour and can be programmed to detect variants of the SARS-CoV-2 virus.
MIT-Jordan Abdul Hameed Shoman Foundation Seed Fund winners announced.
Four times faster than conventional PCR methods, new RADICA approach is highly specific, sensitive, and resistant to inhibitors.
The sensor technology could also be used to create clothing that detects a variety of pathogens and other threats.
Novel method, developed by McGovern Institute researchers, may lead to safer, more efficient gene therapies.
Kytopen is speeding up both discovery and delivery of engineered cell therapies with its transformative Flowfect platforms.
KSQ Therapeutics uses technology created at MIT to study the role of every human gene in disease biology.
Kano Therapeutics was one of eight finalists to pitch at the virtual competition.
Pablo Jarillo-Herrero, Aviv Regev, Susan Solomon, and Feng Zhang are the recipients of distinguished awards for major contributions to science.